Services
Online Inquiry
For research use only. Not intended for any clinical use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Comprehensive Non-Human Primate (NHP) based Preclinical Research Services
Are you currently facing long drug development cycles and challenges in translating preclinical data to human trials? At Creative Biolabs, our comprehensive non-human primate (NHP) based preclinical research services help you accelerate drug discovery and obtain highly predictive, translatable data. Through advanced disease modeling, state-of-the-art bioanalysis platforms, and extensive experience with NHP models, we provide the crucial insights you need to move confidently toward clinical development.
Overview of Non-Human Primate Preclinical Research
NHPs play a pivotal role in bridging laboratory discoveries with clinical translation. With their close genetic, immunological, and physiological resemblance to humans, NHPs provide unparalleled predictive value in evaluating drug metabolism, therapeutic efficacy, and safety. As a result, they remain the gold standard model for vaccine development, cell and gene therapy evaluation, and complex biologics assessment. At Creative Biolabs, we integrate high-quality NHP biospecimens with tailored preclinical services—ranging from PK/PD studies and toxicology to immune profiling and disease modeling. This comprehensive approach enables our clients to generate robust, translatable data while streamlining the path toward clinical success.
Fig.1 Overview of Disease Models, Neurofunctional Studies, and Imaging Methods in NHPs.1
Service Category Navigation
01
Sample Collection & Biobanking
02
DMPK & PK/PD Evaluation
03
Safety & Toxicology
04
Pharmacology & Efficacy
05
Bioanalysis & Biomarker
Ready to advance your project with a reliable partner?
Capability and Trust Endorsement
Creative Biolabs' commitment to scientific excellence is backed by robust data and a history of successful partnerships. Our state-of-the-art facilities and experienced team ensure that every study we conduct meets the highest standards of quality and reproducibility.
- Sample Processing Volume: Over 10,000 samples processed annually, enabling high-throughput research.
- Pass Rate: A 99% pass rate on all studies, reflecting our rigorous quality control.
- Number of Species: Access to 7+ NHP species, including Cynomolgus, Rhesus, and baboons.
- Time to Expected Results: Average of 4-6 weeks to deliver comprehensive study reports.
Collaboration Logo Wall
Why Choose Us?
Choosing the right preclinical partner is paramount to the success of your research, and Creative Biolabs stands out as a leader in comprehensive NHP services. Our decades of experience have enabled us to refine our processes, offering a unique blend of scientific rigor and client-focused service.
- Exceptional Response Speed: Our dedicated project management team and streamlined processes ensure rapid response times, from initial inquiry to final report delivery. We understand the value of your time and are committed to keeping your project on an accelerated timeline.
- Diverse NHP Resources: We maintain access to a wide variety of NHP species and robust animal housing, allowing us to select the optimal model for your specific research goals. This diversity is crucial for generating the most relevant and translatable data.
- Complete Customization: We believe in a collaborative approach. Our scientists work closely with your team to design and execute bespoke studies that are precisely tailored to your project's unique requirements, rather than offering a one-size-fits-all solution.
- Unparalleled Reporting Depth: Beyond basic data, our reports provide comprehensive analysis, including detailed bioanalytical results, advanced imaging data (e.g., PET/CT), histopathology, and expert interpretation. We don't just give you data; we give you actionable insights.
Frequently Asked Questions
Q: How can Creative Biolabs ensure my study is designed for my specific drug and indication?
A: We specialize in customized study design. Our scientific team partners with you from the very beginning to understand your compound, its mechanism of action, and your research goals. This collaborative approach allows us to select the most appropriate NHP species and design a bespoke study protocol that delivers the most relevant and meaningful data for your specific project.
Q: What measures does Creative Biolabs take to ensure ethical animal care during NHP studies?
A: Ethical animal care is a cornerstone of our operations. Our facilities adhere to the highest international standards, and we have a dedicated team focused on animal welfare. We ensure all procedures are conducted with the utmost care, to not only guarantee the well-being of the animals but also the integrity of your study data.
Q: How long does a typical preclinical NHP study take to complete, and can you accommodate urgent timelines?
A: The timeline for a study varies based on its complexity and duration. However, we pride ourselves on our responsiveness and efficient project management. Our team works proactively to streamline every step of the process, from protocol development to data reporting, to deliver results as quickly as possible without compromising on quality. We are always willing to discuss your specific timeline needs to see how we can best support you.
Q: What kind of data and reporting can I expect from a study with Creative Biolabs?
A: You can expect comprehensive and meticulously detailed reports. Our data packages include everything from raw data and statistical analysis to expert interpretation and conclusions. Depending on the study, this can encompass PK/PD parameters, biomarker analysis, safety and toxicity profiles, advanced imaging results, and histopathology. We provide you with a complete picture.
Q: What are the key advantages of using Creative Biolabs' NHP services over a rodent model for certain diseases?
A: For complex diseases, especially in areas like neuroscience, immunology, and metabolic disorders, NHPs offer superior translatability due to their close physiological and genetic similarity to humans. While rodent models are valuable, NHPs can more accurately predict a drug's behavior and efficacy, significantly de-risking your clinical development program and reducing the chance of failure in later stages.
Contact Us
Creative Biolabs' comprehensive NHP-based preclinical research services offer a powerful solution for accelerating your drug development pipeline. Our deep scientific expertise, state-of-art facilities, and collaborative approach ensure that your research is not only efficient but also produces high-quality, translatable data. By partnering with us, you gain access to a full suite of services, from customized study design to in-depth data analysis, all centered around the unmatched power of non-human primate models. Our team of experts is eager to discuss your project and demonstrate how our tailored NHP services can help you achieve your goals.
Reference
- Qiao, Nan, et al. "Update on nonhuman primate models of brain disease and related research tools." Biomedicines 11.9 (2023): 2516. Distributed under Open Access license CC BY 4.0, without modification. DOI: https://doi.org/10.3390/biomedicines11092516.